0
     

Report Added
Report already added
Anthrax Vaccines Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Anthrax Vaccines Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax._x000D_
_x000D_
This report contains market size and forecasts of Anthrax Vaccines in India, including the following market information:_x000D_
India Anthrax Vaccines Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Anthrax Vaccines Market Consumption, 2015-2020, 2021-2026, (M Doses)_x000D_
India Anthrax Vaccines Production Capacity, 2015-2020, 2021-2026, (M Doses)_x000D_
Top Five Competitors in India Anthrax Vaccines Market 2019 (%)_x000D_
The global Anthrax Vaccines market was valued at 603.8 million in 2019 and is projected to reach US$ 799.6 million by 2026, at a CAGR of 7.3% during the forecast period. While the Anthrax Vaccines market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Anthrax Vaccines production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Anthrax Vaccines Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Doses)_x000D_
India Anthrax Vaccines Market Segment Percentages, By Type, 2019 (%)_x000D_
Live Vaccines_x000D_
Cell free PA Vaccines_x000D_
_x000D_
India Anthrax Vaccines Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Doses)_x000D_
India Anthrax Vaccines Market Segment Percentages, By Application, 2019 (%)_x000D_
Human Use_x000D_
Animal Use_x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Anthrax Vaccines Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Anthrax Vaccines Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Anthrax Vaccines Market Competitors Sales, by Players 2015-2020 (Estimated), (M Doses)_x000D_
Total India Anthrax Vaccines Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Emergent BioSolutions_x000D_
Merial_x000D_
Merck_x000D_
Zoetis_x000D_
Bayer Sanidad Animal_x000D_
Colorado Serum_x000D_
PharmAthene_x000D_
Tiankang_x000D_
Biogénesis-Bago_x000D_
CAVAC_x000D_
Rosenbusch_x000D_
Agrovet_x000D_
Vecol_x000D_
CVCRI_x000D_
IVPM_x000D_
Prondil_x000D_
CDV_x000D_
Indian Immunologicals_x000D_
Botswana Vaccine Institute_x000D_
Ceva Santé Animale_x000D_
Intervac_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Anthrax Vaccines Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Anthrax Vaccines Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Anthrax Vaccines Overall Market Size_x000D_
2.1 India Anthrax Vaccines Market Size: 2020 VS 2026_x000D_
2.2 India Anthrax Vaccines Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Anthrax Vaccines Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Anthrax Vaccines Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Anthrax Vaccines Companies Ranked by Revenue_x000D_
3.3 India Anthrax Vaccines Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Anthrax Vaccines Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Anthrax Vaccines Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Anthrax Vaccines Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Anthrax Vaccines Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in India_x000D_
3.8.1 List of India Tier 1 Anthrax Vaccines Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Anthrax Vaccines Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Anthrax Vaccines Market Size Markets, 2020 & 2026_x000D_
4.1.2 Live Vaccines_x000D_
4.1.3 Cell free PA Vaccines_x000D_
4.2 By Type - India Anthrax Vaccines Revenue & Forecasts_x000D_
4.2.1 By Type - India Anthrax Vaccines Revenue, 2015-2020_x000D_
4.2.2 By Type - India Anthrax Vaccines Revenue, 2021-2026_x000D_
4.2.3 By Type - India Anthrax Vaccines Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Anthrax Vaccines Sales & Forecasts_x000D_
4.3.1 By Type - India Anthrax Vaccines Sales, 2015-2020_x000D_
4.3.2 By Type - India Anthrax Vaccines Sales, 2021-2026_x000D_
4.3.3 By Type - India Anthrax Vaccines Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Anthrax Vaccines Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Anthrax Vaccines Market Size, 2020 & 2026_x000D_
5.1.2 Human Use_x000D_
5.1.3 Animal Use_x000D_
5.2 By Application - India Anthrax Vaccines Revenue & Forecasts_x000D_
5.2.1 By Application - India Anthrax Vaccines Revenue, 2015-2020_x000D_
5.2.2 By Application - India Anthrax Vaccines Revenue, 2021-2026_x000D_
5.2.3 By Application - India Anthrax Vaccines Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Anthrax Vaccines Sales & Forecasts_x000D_
5.3.1 By Application - India Anthrax Vaccines Sales, 2015-2020_x000D_
5.3.2 By Application - India Anthrax Vaccines Sales, 2021-2026_x000D_
5.3.3 By Application - India Anthrax Vaccines Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Anthrax Vaccines Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 Emergent BioSolutions_x000D_
6.1.1 Emergent BioSolutions Corporate Summary_x000D_
6.1.2 Emergent BioSolutions Business Overview_x000D_
6.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings_x000D_
6.1.4 Emergent BioSolutions Sales and Revenue in India (2015-2020)_x000D_
6.1.5 Emergent BioSolutions Key News_x000D_
6.2 Merial_x000D_
6.2.1 Merial Corporate Summary_x000D_
6.2.2 Merial Business Overview_x000D_
6.2.3 Merial Anthrax Vaccines Major Product Offerings_x000D_
6.2.4 Merial Sales and Revenue in India (2015-2020)_x000D_
6.2.5 Merial Key News_x000D_
6.3 Merck_x000D_
6.3.1 Merck Corporate Summary_x000D_
6.3.2 Merck Business Overview_x000D_
6.3.3 Merck Anthrax Vaccines Major Product Offerings_x000D_
6.3.4 Merck Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Merck Key News_x000D_
6.4 Zoetis_x000D_
6.4.1 Zoetis Corporate Summary_x000D_
6.4.2 Zoetis Business Overview_x000D_
6.4.3 Zoetis Anthrax Vaccines Major Product Offerings_x000D_
6.4.4 Zoetis Sales and Revenue in India (2015-2020)_x000D_
6.4.5 Zoetis Key News_x000D_
6.5 Bayer Sanidad Animal_x000D_
6.5.1 Bayer Sanidad Animal Corporate Summary_x000D_
6.5.2 Bayer Sanidad Animal Business Overview_x000D_
6.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings_x000D_
6.5.4 Bayer Sanidad Animal Sales and Revenue in India (2015-2020)_x000D_
6.5.5 Bayer Sanidad Animal Key News_x000D_
6.6 Colorado Serum_x000D_
6.6.1 Colorado Serum Corporate Summary_x000D_
6.6.2 Colorado Serum Business Overview_x000D_
6.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings_x000D_
6.6.4 Colorado Serum Sales and Revenue in India (2015-2020)_x000D_
6.6.5 Colorado Serum Key News_x000D_
6.7 PharmAthene_x000D_
6.6.1 PharmAthene Corporate Summary_x000D_
6.6.2 PharmAthene Business Overview_x000D_
6.6.3 PharmAthene Anthrax Vaccines Major Product Offerings_x000D_
6.4.4 PharmAthene Sales and Revenue in India (2015-2020)_x000D_
6.7.5 PharmAthene Key News_x000D_
6.8 Tiankang_x000D_
6.8.1 Tiankang Corporate Summary_x000D_
6.8.2 Tiankang Business Overview_x000D_
6.8.3 Tiankang Anthrax Vaccines Major Product Offerings_x000D_
6.8.4 Tiankang Sales and Revenue in India (2015-2020)_x000D_
6.8.5 Tiankang Key News_x000D_
6.9 Biogénesis-Bago_x000D_
6.9.1 Biogénesis-Bago Corporate Summary_x000D_
6.9.2 Biogénesis-Bago Business Overview_x000D_
6.9.3 Biogénesis-Bago Anthrax Vaccines Major Product Offerings_x000D_
6.9.4 Biogénesis-Bago Sales and Revenue in India (2015-2020)_x000D_
6.9.5 Biogénesis-Bago Key News_x000D_
6.10 CAVAC_x000D_
6.10.1 CAVAC Corporate Summary_x000D_
6.10.2 CAVAC Business Overview_x000D_
6.10.3 CAVAC Anthrax Vaccines Major Product Offerings_x000D_
6.10.4 CAVAC Sales and Revenue in India (2015-2020)_x000D_
6.10.5 CAVAC Key News_x000D_
6.11 Rosenbusch_x000D_
6.11.1 Rosenbusch Corporate Summary_x000D_
6.11.2 Rosenbusch Anthrax Vaccines Business Overview_x000D_
6.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings_x000D_
6.11.4 Rosenbusch Sales and Revenue in India (2015-2020)_x000D_
6.11.5 Rosenbusch Key News_x000D_
6.12 Agrovet_x000D_
6.12.1 Agrovet Corporate Summary_x000D_
6.12.2 Agrovet Anthrax Vaccines Business Overview_x000D_
6.12.3 Agrovet Anthrax Vaccines Major Product Offerings_x000D_
6.12.4 Agrovet Sales and Revenue in India (2015-2020)_x000D_
6.12.5 Agrovet Key News_x000D_
6.13 Vecol_x000D_
6.13.1 Vecol Corporate Summary_x000D_
6.13.2 Vecol Anthrax Vaccines Business Overview_x000D_
6.13.3 Vecol Anthrax Vaccines Major Product Offerings_x000D_
6.13.4 Vecol Sales and Revenue in India (2015-2020)_x000D_
6.13.5 Vecol Key News_x000D_
6.14 CVCRI_x000D_
6.14.1 CVCRI Corporate Summary_x000D_
6.14.2 CVCRI Anthrax Vaccines Business Overview_x000D_
6.14.3 CVCRI Anthrax Vaccines Major Product Offerings_x000D_
6.14.4 CVCRI Sales and Revenue in India (2015-2020)_x000D_
6.14.5 CVCRI Key News_x000D_
6.15 IVPM_x000D_
6.15.1 IVPM Corporate Summary_x000D_
6.15.2 IVPM Anthrax Vaccines Business Overview_x000D_
6.15.3 IVPM Anthrax Vaccines Major Product Offerings_x000D_
6.15.4 IVPM Sales and Revenue in India (2015-2020)_x000D_
6.15.5 IVPM Key News_x000D_
6.16 Prondil_x000D_
6.16.1 Prondil Corporate Summary_x000D_
6.16.2 Prondil Anthrax Vaccines Business Overview_x000D_
6.16.3 Prondil Anthrax Vaccines Major Product Offerings_x000D_
6.16.4 Prondil Sales and Revenue in India (2015-2020)_x000D_
6.16.5 Prondil Key News_x000D_
6.17 CDV_x000D_
6.17.1 CDV Corporate Summary_x000D_
6.17.2 CDV Anthrax Vaccines Business Overview_x000D_
6.17.3 CDV Anthrax Vaccines Major Product Offerings_x000D_
6.17.4 CDV Sales and Revenue in India (2015-2020)_x000D_
6.17.5 CDV Key News_x000D_
6.18 Indian Immunologicals_x000D_
6.18.1 Indian Immunologicals Corporate Summary_x000D_
6.18.2 Indian Immunologicals Anthrax Vaccines Business Overview_x000D_
6.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings_x000D_
6.18.4 Indian Immunologicals Sales and Revenue in India (2015-2020)_x000D_
6.18.5 Indian Immunologicals Key News_x000D_
6.19 Botswana Vaccine Institute_x000D_
6.19.1 Botswana Vaccine Institute Corporate Summary_x000D_
6.19.2 Botswana Vaccine Institute Anthrax Vaccines Business Overview_x000D_
6.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings_x000D_
6.19.4 Botswana Vaccine Institute Sales and Revenue in India (2015-2020)_x000D_
6.19.5 Botswana Vaccine Institute Key News_x000D_
6.20 Ceva Santé Animale_x000D_
6.20.1 Ceva Santé Animale Corporate Summary_x000D_
6.20.2 Ceva Santé Animale Anthrax Vaccines Business Overview_x000D_
6.20.3 Ceva Santé Animale Anthrax Vaccines Major Product Offerings_x000D_
6.20.4 Ceva Santé Animale Sales and Revenue in India (2015-2020)_x000D_
6.20.5 Ceva Santé Animale Key News_x000D_
6.21 Intervac_x000D_
6.21.1 Intervac Corporate Summary_x000D_
6.21.2 Intervac Anthrax Vaccines Business Overview_x000D_
6.21.3 Intervac Anthrax Vaccines Major Product Offerings_x000D_
6.21.4 Intervac Sales and Revenue in India (2015-2020)_x000D_
6.21.5 Intervac Key News_x000D_
6.22 JOVAC_x000D_
6.22.1 JOVAC Corporate Summary_x000D_
6.22.2 JOVAC Anthrax Vaccines Business Overview_x000D_
6.22.3 JOVAC Anthrax Vaccines Major Product Offerings_x000D_
6.22.4 JOVAC Sales and Revenue in India (2015-2020)_x000D_
6.22.5 JOVAC Key News_x000D_
_x000D_
7 Anthrax Vaccines Production Capacity, Export and Import Analysis_x000D_
7.1 Anthrax Vaccines Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Anthrax Vaccines Production Capacity, 2015-2026_x000D_
7.1.2 India Anthrax Vaccines Production 2015-2026_x000D_
7.1.3 India Anthrax Vaccines Production Value 2015-2026_x000D_
7.2 Key Local Anthrax Vaccines Manufacturers in India_x000D_
7.2.1 India Key Local Anthrax Vaccines Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Anthrax Vaccines Manufacturers Production_x000D_
7.2.3 India Key Local Anthrax Vaccines Manufacturers Production Value_x000D_
7.2.4 The Proportion of Anthrax Vaccines Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Anthrax Vaccines Export and Import in India_x000D_
7.3.1 India Anthrax Vaccines Export Market_x000D_
7.3.2 India Anthrax Vaccines Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Anthrax Vaccines Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Anthrax Vaccines Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Anthrax Vaccines Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Anthrax Vaccines in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Anthrax Vaccines Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Anthrax Vaccines Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Anthrax Vaccines Sales by Companies, (M Doses), 2015-2020_x000D_
Table 6. India Anthrax Vaccines Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Anthrax Vaccines Price (2015-2020) (USD/K Doses)_x000D_
Table 8. India Manufacturers Anthrax Vaccines Product Type_x000D_
Table 9. List of India Tier 1 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Anthrax Vaccines Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Anthrax Vaccines Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Anthrax Vaccines Sales in India (M Doses), 2015-2020_x000D_
Table 14. By Type - Anthrax Vaccines Sales in India (M Doses), 2021-2026_x000D_
Table 15. By Application - Anthrax Vaccines Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Anthrax Vaccines Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Anthrax Vaccines Sales in India, (M Doses), 2015-2020_x000D_
Table 18. By Application - Anthrax Vaccines Sales in India, (M Doses), 2021-2026_x000D_
Table 19. Emergent BioSolutions Corporate Summary_x000D_
Table 20. Emergent BioSolutions Anthrax Vaccines Product Offerings_x000D_
Table 21. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 22. Merial Corporate Summary_x000D_
Table 23. Merial Anthrax Vaccines Product Offerings_x000D_
Table 24. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 25. Merck Corporate Summary_x000D_
Table 26. Merck Anthrax Vaccines Product Offerings_x000D_
Table 27. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 28. Zoetis Corporate Summary_x000D_
Table 29. Zoetis Anthrax Vaccines Product Offerings_x000D_
Table 30. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 31. Bayer Sanidad Animal Corporate Summary_x000D_
Table 32. Bayer Sanidad Animal Anthrax Vaccines Product Offerings_x000D_
Table 33. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 34. Colorado Serum Corporate Summary_x000D_
Table 35. Colorado Serum Anthrax Vaccines Product Offerings_x000D_
Table 36. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 37. PharmAthene Corporate Summary_x000D_
Table 38. PharmAthene Anthrax Vaccines Product Offerings_x000D_
Table 39. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 40. Tiankang Corporate Summary_x000D_
Table 41. Tiankang Anthrax Vaccines Product Offerings_x000D_
Table 42. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 43. Biogénesis-Bago Corporate Summary_x000D_
Table 44. Biogénesis-Bago Anthrax Vaccines Product Offerings_x000D_
Table 45. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 46. CAVAC Corporate Summary_x000D_
Table 47. CAVAC Anthrax Vaccines Product Offerings_x000D_
Table 48. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 49. Rosenbusch Corporate Summary_x000D_
Table 50. Rosenbusch Anthrax Vaccines Product Offerings_x000D_
Table 51. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 52. Agrovet Corporate Summary_x000D_
Table 53. Agrovet Anthrax Vaccines Product Offerings_x000D_
Table 54. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 55. Vecol Corporate Summary_x000D_
Table 56. Vecol Anthrax Vaccines Product Offerings_x000D_
Table 57. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 58. CVCRI Corporate Summary_x000D_
Table 59. CVCRI Anthrax Vaccines Product Offerings_x000D_
Table 60. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 61. IVPM Corporate Summary_x000D_
Table 62. IVPM Anthrax Vaccines Product Offerings_x000D_
Table 63. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 64. Prondil Corporate Summary_x000D_
Table 65. Prondil Anthrax Vaccines Product Offerings_x000D_
Table 66. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 67. CDV Corporate Summary_x000D_
Table 68. CDV Anthrax Vaccines Product Offerings_x000D_
Table 69. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 70. Indian Immunologicals Corporate Summary_x000D_
Table 71. Indian Immunologicals Anthrax Vaccines Product Offerings_x000D_
Table 72. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 73. Botswana Vaccine Institute Corporate Summary_x000D_
Table 74. Botswana Vaccine Institute Anthrax Vaccines Product Offerings_x000D_
Table 75. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 76. Ceva Santé Animale Corporate Summary_x000D_
Table 77. Ceva Santé Animale Anthrax Vaccines Product Offerings_x000D_
Table 78. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 79. Intervac Corporate Summary_x000D_
Table 80. Intervac Anthrax Vaccines Product Offerings_x000D_
Table 81. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 82. JOVAC Corporate Summary_x000D_
Table 83. JOVAC Anthrax Vaccines Product Offerings_x000D_
Table 84. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2015-2020)_x000D_
Table 85. Anthrax Vaccines Production Capacity (M Doses) of Local Manufacturers in India, 2015-2020_x000D_
Table 86. Anthrax Vaccines Production (M Doses) of Local Manufacturers in India, 2015-2020_x000D_
Table 87. India Anthrax Vaccines Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 88. Anthrax Vaccines Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 89. India Anthrax Vaccines Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 90. The Percentage of Anthrax Vaccines Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 91. The Percentage of Anthrax Vaccines Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 92. Dangeguojia Anthrax Vaccines Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 93. Raw Materials and Suppliers_x000D_
Table 94. Anthrax Vaccines Downstream Clients in India_x000D_
Table 95. Anthrax Vaccines Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Anthrax Vaccines Segment by Type_x000D_
Figure 2. Anthrax Vaccines Segment by Application_x000D_
Figure 3. Dangeguojia Anthrax Vaccines Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Anthrax Vaccines Market Size in India, (US$, Mn) & (M Doses): 2020 VS 2026_x000D_
Figure 6. India Anthrax Vaccines Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Anthrax Vaccines Sales in India: 2015-2026 (M Doses)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Vaccines Revenue in 2019_x000D_
Figure 9. By Type - India Anthrax Vaccines Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Anthrax Vaccines Market Share, 2015-2020_x000D_
Figure 11. By Type - India Anthrax Vaccines Market Share, 2020-2026_x000D_
Figure 12. By Type - India Anthrax Vaccines Price (USD/K Doses), 2015-2026_x000D_
Figure 13. By Application - Anthrax Vaccines Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Anthrax Vaccines Market Share, 2015-2020_x000D_
Figure 15. By Application - India Anthrax Vaccines Market Share, 2020-2026_x000D_
Figure 16. By Application -India Anthrax Vaccines Price (USD/K Doses), 2015-2026_x000D_
Figure 17. India Anthrax Vaccines Production Capacity (M Doses), 2015-2026_x000D_
Figure 18. India Anthrax Vaccines Actual Output (M Doses), 2015-2026_x000D_
Figure 19. India Anthrax Vaccines Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Anthrax Vaccines Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Anthrax Vaccines, 2019_x000D_
Figure 22. PEST Analysis for India Anthrax Vaccines Market in 2020_x000D_
Figure 23. Anthrax Vaccines Market Opportunities & Trends in India_x000D_
Figure 24. Anthrax Vaccines Market Drivers in India_x000D_
Figure 25. Anthrax Vaccines Market Restraints in India_x000D_
Figure 26. Anthrax Vaccines Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Anthrax Vaccines Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW